Health authorities in Pakistan have raised a serious alert after discovering counterfeit and unsafe medicines in the market. The issue has sparked concern about patient safety and the circulation of low-quality drugs.
According to Beyond Time News, the warning highlights the growing risk of fake pharmaceutical products reaching consumers.
Six Medicines Found Unsafe
The Drug Regulatory Authority of Pakistan has identified six medicines in Punjab that failed laboratory testing.
Officials confirmed that these products were either fake or below standard quality and could pose serious health risks.
Immediate Removal Ordered
Authorities said specific batches of these medicines were found to be dangerous and not manufactured in approved facilities.
According to Beyond Time News, all affected stocks have been ordered to be removed from pharmacies and medical stores without delay.
Eye Drops and Other Medicines Included
Among the flagged products are glaucoma eye drops, which were found to be substandard. Officials warned that their use could seriously harm eyesight.
Several medicines used for pregnancy care and women’s health were also identified as counterfeit.
Antifungal Drug and Injection Also Affected
A batch of antifungal tablets has been declared fake, raising concerns about ineffective treatment of infections.
In addition, a hormone-related injection used for medical treatments has also been confirmed as counterfeit.
Pakistan takes major steps towards local ‘vaccine manufacturing’
Strict Action and Public Advisory
Drug inspectors have been directed to seize all available stocks from pharmacies, distributors, and medical outlets across the country.
According to Beyond Time News, the public has been advised to carefully check packaging, batch numbers, and official registration details before using any medicine. Citizens are also urged to report suspicious products to authorities.
Conclusion
The alert serves as a strong reminder of the dangers posed by counterfeit medicines. According to Beyond Time News, strict enforcement and public awareness are essential to protect patients and ensure safe access to genuine medical products.
